Measuring skin water loss predicts anaphylaxis during food allergy tests

The method aims to detect the life threatening reaction before epinephrine injections are necessary

10:19 AM

Author | Patricia DeLacey

white bowls with allergens in each one
Getty Images

Food allergies can quickly turn a casual meal into a life-threatening situation.

Anaphylaxis – a severe allergic reaction that may include a skin rash, nausea, vomiting, difficulty breathing, and shock – from a food allergy sends 200,000 people to the emergency room annually in the United States.

Because pinpointing a food allergy could mean life or death, an accurate diagnosis is critical.

Oral food challenges – when a patient ingests increasing doses up to a full serving of the suspected food allergen under supervision of a medical provider – are the diagnostic standard as skin and blood allergy tests have high false positive rates.

Although a highly accurate diagnostic test, patients often experience anaphylaxis during oral food challenges necessitating an epinephrine injection.

SEE ALSO: Vaccine suppresses peanut allergies in mice

A team of University of Michigan researchers developed a method that measures water loss from the skin to predict anaphylaxis during oral food challenges before it becomes clinically evident.

The results are published in The Journal of Clinical Investigation.

“This method could enhance the ability to detect and predict anaphylaxis during oral food challenges prior to the need for epinephrine, greatly improving patient safety and comfort,” said Charles Schuler, M.D., lead author of the study and an immunologist at Michigan Medicine.

Building on existing research

During anaphylaxis, the dilation or widening of the blood vessels increases heat and water loss from the surface of the skin.

Previous research has assessed facial thermography, which uses a specialized camera to detect heat patterns emitted from the skin, as a method to predict anaphylaxis.

However, this method requires optics expertise, tightly controlled conditions and for the patient to sit still for an extended period – making this an impractical choice, especially for assessing food allergies in children.

The researchers validated the use of transepidermal water loss, a measurement that represents the amount of water that escapes from a given skin area per hour, by comparing its ability to detect anaphylaxis with biochemical and clinical observation methods.

They found that transepidermal water loss increases during food allergy reactions and anaphylaxis.

The rise in skin water loss correlated with biochemical markers of anaphylaxis and substantially preceded clinical detection of anaphylaxis.

SEE ALSO: The Do’s and Don’ts of Preventing Peanut Allergies in Babies

“Transepidermal water loss measurement can be done in office without specialized equipment, affixed to the skin and works in children making it a vast improvement from previous attempts at early anaphylaxis detection methods,” said Schuler.

Schuler’s research group is currently recruiting participants aged 6 months to 5 years old for a pilot clinical trial, Predicting Peanut Anaphylaxis and Reducing Epinephrine, that monitors transepidermal water loss from the forearm during a peanut allergy food challenge.

Results will help pinpoint values associated with anaphylaxis to determine “stopping rules” to end oral food challenges, hopefully reducing the need for epinephrine injections.

In addition to Schuler, the University of Michigan research team included Kelly O’Shea, M.D., Jonathan Troost, Ph.D., Bridgette Kaul, Christoper Launius, Jayme Cannon, David Manthei, M.D., George Freigeh, M.D., Georgiana Sanders, M.D., M.S., Simon Hogan, Ph.D., Nicholas Lukacs, Ph.D., and James Baker Jr., M.D.

This study was made possible in part by the University of Michigan Medical School Central Biorepository.

Paper cited: “Transepidermal water loss rises before food anaphylaxis and predicts food challenge outcomes,” Journal of Clinical Investigation. DOI: 10.1172/JCI168965


More Articles About:

All Research Topics Basic Science and Laboratory Research Food Allergy Anaphylaxis (IgE) Allergy Testing Allergy and Immunology Allergic Conditions
Health Lab word mark overlaying blue cells

Health Lab

Explore thousands of health news & research stories by visiting the Health Lab homepage for more.

Media Contact

University Hospital at U-M Health in the spring with flowering trees in foreground and Survival Flight helicopter visible

Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe

Featured News & Stories

liver with yellow circles over it
Health Lab

Evolving causes, diagnosis of drug-induced liver injury

The causes of drug-induced liver injury have evolved over the last 20 years, according to a review in Hepatology Communications.
pills close up some powder some round some long
Health Lab

What’s the latest on 7-OH and kratom availability and addiction care?

The United States Drug Enforcement Agency has extended public comment on proposed temporary rescheduling of 7-OH and has rescheduled three other synthetic opioids, effectively removing them the market, leaving natural leaf kratom available amid a shortage of addiction treatment providers.
woman itching skin orange blue button down
Health Lab

A first-of-its-kind treatment for mastocytosis

A new drug called Avapritinib achieved longterm safety approval for indolent systemic mastocytosis.
kid at table not wanting to eat breakfast with parent blurred in background white coloring milk on table
Health Lab

Many parents face challenges getting kids to eat a healthy breakfast before school

Three-quarters of parents report at least one barrier to their child starting the day with a healthy meal on a typical school day, according to the University of Michigan Health C.S. Mott Children’s Hospital National Poll on Children’s Health.
Microscope images of prostate cancer cells
Health Lab

New drug combination may help treat advanced prostate cancer

University of Michigan researchers found that combining BET bromodomain and DNMT inhibitors may slow the growth of treatment-resistant prostate cancer by targeting transdifferentiated tumors.
woman with older woman at table helping on tablet
Health Lab

First person-centered measure of dementia caregiving styles improves partner, patient outcomes

First person-centered measure of dementia caregiving styles improves partner and patient outcomes.